CORT - Corcept Therapeutics Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.87B
Enterprise Value 3
1.66B
Trailing P/E
22.79
Forward P/E 1
16.54
PEG Ratio (5 yr expected) 1
-0.51
Price/Sales (ttm)
6.54
Price/Book (mrq)
5.53
Enterprise Value/Revenue 3
5.81
Enterprise Value/EBITDA 6
16.24

Trading Information

Stock Price History

Beta (3Y Monthly) 1.33
52-Week Change 326.98%
S&P500 52-Week Change 313.42%
52 Week High 319.48
52 Week Low 39.14
50-Day Moving Average 314.48
200-Day Moving Average 312.34

Share Statistics

Avg Vol (3 month) 3696.82k
Avg Vol (10 day) 31.09M
Shares Outstanding 5114.28M
Float 96.31M
% Held by Insiders 19.71%
% Held by Institutions 179.82%
Shares Short (Oct 31, 2019) 420.07M
Short Ratio (Oct 31, 2019) 434.5
Short % of Float (Oct 31, 2019) 426.22%
Short % of Shares Outstanding (Oct 31, 2019) 417.59%
Shares Short (prior month Sep 30, 2019) 420.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 30.41%
Operating Margin (ttm)35.56%

Management Effectiveness

Return on Assets (ttm)19.03%
Return on Equity (ttm)29.23%

Income Statement

Revenue (ttm)285.42M
Revenue Per Share (ttm)2.49
Quarterly Revenue Growth (yoy)26.50%
Gross Profit (ttm)246.03M
EBITDA 102.03M
Net Income Avi to Common (ttm)86.81M
Diluted EPS (ttm)0.71
Quarterly Earnings Growth (yoy)48.40%

Balance Sheet

Total Cash (mrq)231.64M
Total Cash Per Share (mrq)2.03
Total Debt (mrq)770k
Total Debt/Equity (mrq)0.23
Current Ratio (mrq)8.25
Book Value Per Share (mrq)2.93

Cash Flow Statement

Operating Cash Flow (ttm)109.18M
Levered Free Cash Flow (ttm)76.77M